“Evaluation of Anaphylactic Reaction As an Adverse Event for Perindopril Erbumine Tablets”. International Current Pharmaceutical Journal, vol. 3, no. 4, Mar. 2014, pp. 254-8, https://doi.org/10.3329/icpj.v3i4.18265.